MYELOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
MYELOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
批准号:
3126836
负责人:
EDWIN L THOMAS
金额:
$4.83万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-04-01 至 1989-12-31
关键词:
ammonia bactericidal immunity cell population study chlorine cytotoxicity erythrocytes granule hemoglobin human subject hydrogen peroxide immunoregulation immunotoxicity lysosomes manganese myeloperoxidase neutrophil oxidation reduction reaction oxidizing agents oxidoreductase phagocytosis polylysine reduction superoxide dismutase superoxides
中文摘要
刺激嗜中性白细胞导致分泌有毒的
蛋白质和酶髓过氧化物酶(MPO)从
细胞质颗粒和激活中性粒细胞氧(O2)
代谢,产生有毒的氧化剂。 神经毒素
通过杀死入侵的微生物来对抗感染,
导致炎症组织破坏。 远景目标纲要
是为了描述氧化剂,确定它们在
抗微生物活性和对宿主细胞的损伤,并阐明
调节其效力和选择性的机制。 的
工作假设是过氧化氢(H2 O2)和产物
MPO/H_2O_2/Cl ~-体系的主要氧化产物是MPO/H_2O_2/Cl ~-
毒素 超氧化物(02-)是白细胞02的第一个产物
02-的主要作用不是作为毒素。
相反,O2-是H2 O2生产中的中间体和氧化剂
对于细胞外还原剂如抗坏血酸盐(维生素C)和
巯基化合物。 这些还原剂被02-
增加H2 O2产量并消耗还原剂,
它们不能解毒H2 O2和MPO系统的产物。
MPO系统的毒性也受氨(NH 4+)调节,
和来自细胞质颗粒的富含赖氨酸的肽。 MPO
催化H2 O2氧化C1-生成次氯酸
(HOC 1),其与NH 4+反应以产生杀菌剂
一氯胺(NH 2Cl)。 然而,NH 2C 1也可以抑制
通过抑制中性粒细胞O2代谢和NH 4+或
NH_2C_1可抑制MPO的分泌。 HOC 1与
赖氨酸-肽产生相对无毒但寿命长的
肽-氯胺。 拟议的研究将描述
O2-、H2 O2和MPO系统的产物与
抗坏血酸和其他细胞外还原剂,并检查影响
还原剂的抗菌和细胞毒活性
孤立的中性粒细胞 锰(Mn 2+)促进
将研究MPO对还原剂的氧化,以确定
MPO是否可以作为氧化酶并产生毒性氧化剂
在具有缺陷O2代谢的嗜中性粒细胞中。 NH 4+的影响
对中性粒细胞O2代谢、MPO分泌和抗菌
活性将被测量,并且赖氨酸-肽的相互作用
将使用纯化的肽研究MPO系统,
MPO。 这些研究将提供新的见解,
中性粒细胞功能中的氧化剂和还原剂,
用于在抑制感染的同时对抗感染的改进方法
对宿主组织的损害。
英文摘要
Stimulation of neutrophilic leukocytes results in secretion of toxic
proteins and the enzyme myeloperoxidase (MPO) from
cytoplasmic granules and activates neutrophil oxygen (O2)
metabolism, which produces toxic oxidants. Neutrophil toxins
combat infection by killing invading microorganisms but also
contribute to inflammatory tissue destruction. Long-range goals
are to characterize the oxidants, determine their role in
antimicrobial activity and damage to host cells, and elucidate
mechanisms that regulate their potency and selectivity. The
working hypothesis is that hydrogen peroxide (H202) and products
of the MPO/H202/chloride (C1-) system are the major oxidative
toxins. Superoxide (02-) is the first product of leukocyte 02
metabolism, but the principal role of 02- is not as a toxin.
Instead, 02- is an intermediate in H202 production and an oxidant
for extracellular reductants such as ascorbate (vitamin C) and
sulfhydryl compounds. Oxidation of these reductants by 02-
increases H202 production and consumes the reductants so that
they can't detoxify H202 and products of the MPO system.
Toxicity of the MPO system is also regulated by ammonia (NH4+),
and lysine-rich peptides from the cytoplasmic granules. MPO
catalyzed the oxidation of C1- by H202 to yield hypochlorous acid
(HOC1), which reacts with NH4+ to yield the bactericidal agent
monochloramine (NH2C1). However, NH2C1 can also suppress
toxicity by inhibiting neutrophil 02 metabolism, and NH4+ or
NH2C1 may inhibit MPO secretion. The reaction of HOC1 with
the lysine-peptides yields relatively non-toxic though long-lived
peptide-chloramines. The proposed studies will characterize the
interaction of 02-, H202, and products of the MPO system with
ascorbate and other extracellular reductants, and examine effects
of the reductants on antibacterial and cytotoxic activities of
isolated neutrophils. The ability of manganese (Mn2+) to promote
oxidation of reductants by MPO will be studied, to determine
whether MPO could act as an oxidase and produce toxic oxidants
in neutrophils with defective 02 metabolism. The effect of NH4+
on neutrophil 02 metabolism, MPO secretion, and antibacterial
activity will be measured, and the interaction of lysine-peptides
with the MPO system will be studied using purified peptides and
MPO. These studies will provide new insights into the role of
oxidants and reductants in neutrophil function and may lead to
improved methods for combating infection while suppressing
damage to host tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MYLEOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
-
批准号:3126840
-
项目类别:
-
资助金额:$12.13万
-
财政年份:1990
-
负责人:EDWIN L THOMAS
-
依托单位:
PEROXIDASE IN SALIVA AND PREVENTION OF ORAL DISEASE
-
批准号:3219006
-
项目类别:
-
资助金额:$13.04万
-
财政年份:1990
-
负责人:EDWIN L THOMAS
-
依托单位:
PEROXIDASE IN SALIVA AND PREVENTION OF ORAL DISEASE
-
批准号:3219001
-
项目类别:
-
资助金额:$12.11万
-
财政年份:1990
-
负责人:EDWIN L THOMAS
-
依托单位:
PEROXIDASE IN SALIVA AND PREVENTION OF ORAL DISEASE
-
批准号:3219007
-
项目类别:
-
资助金额:$13.56万
-
财政年份:1990
-
负责人:EDWIN L THOMAS
-
依托单位:
MYLEOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
-
批准号:3126839
-
项目类别:
-
资助金额:$18.28万
-
财政年份:1981
-
负责人:EDWIN L THOMAS
-
依托单位:
MYLEOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
-
批准号:3126838
-
项目类别:
-
资助金额:$17.42万
-
财政年份:1981
-
负责人:EDWIN L THOMAS
-
依托单位:
MYELOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
-
批准号:3126832
-
项目类别:
-
资助金额:$13.52万
-
财政年份:1981
-
负责人:EDWIN L THOMAS
-
依托单位:
MYELOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
-
批准号:3126837
-
项目类别:
-
资助金额:$16.92万
-
财政年份:1981
-
负责人:EDWIN L THOMAS
-
依托单位:
MYELOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
-
批准号:3126835
-
项目类别:
-
资助金额:$12.93万
-
财政年份:1981
-
负责人:EDWIN L THOMAS
-
依托单位:
MYELOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
-
批准号:3126834
-
项目类别:
-
资助金额:$11.12万
-
财政年份:1981
-
负责人:EDWIN L THOMAS
-
依托单位:
MYELOPEROXIDASE AND LEUKOCYTE GRANULE COMPONENTS
-
批准号:3126833
-
项目类别:
-
资助金额:$17.81万
-
财政年份:1981
-
负责人:EDWIN L THOMAS
-
依托单位:
PEROXIDASE IN SALIVA AND PREVENTION OF ORAL DISEASE
-
批准号:3219004
-
项目类别:
-
资助金额:$8.65万
-
财政年份:1976
-
负责人:EDWIN L THOMAS
-
依托单位:
PEROXIDASE IN SALIVA AND PREVENTION OF ORAL DISEASE
-
批准号:3218999
-
项目类别:
-
资助金额:$8.58万
-
财政年份:1976
-
负责人:EDWIN L THOMAS
-
依托单位:
PEROXIDASE IN SALIVA AND PREVENTION OF ORAL DISEASE
-
批准号:3219003
-
项目类别:
-
资助金额:$8.29万
-
财政年份:1976
-
负责人:EDWIN L THOMAS
-
依托单位:
PEROXIDASE IN SALIVA AND PREVENTION OF ORAL DISEASE
-
批准号:3219005
-
项目类别:
-
资助金额:$8.95万
-
财政年份:1976
-
负责人:EDWIN L THOMAS
-
依托单位:
海外基金